Rare disorder with hypergonadotropic hypogonadism

Rare disorder with hypergonadotropic hypogonadism (Orphanet code 181441) is a broad grouping category used in the Orphanet classification system to encompass rare genetic conditions characterized by hypergonadotropic hypogonadism — a form of gonadal failure in which the gonads (ovaries or testes) do not function properly despite elevated levels of the pituitary gonadotropins (follicle-stimulating hormone, FSH, and luteinizing hormone, LH). In this condition, the primary defect lies at the level of the gonads rather than the brain or pituitary gland, leading the body to produce excess gonadotropins in an attempt to stimulate gonadal function. The clinical consequences of hypergonadotropic hypogonadism primarily affect the reproductive and endocrine systems. Key features may include delayed or absent puberty, primary or secondary amenorrhea in females, infertility, reduced or absent development of secondary sexual characteristics, and in some cases ambiguous genitalia. In males, features can include small testes, gynecomastia, and azoospermia. Additional features depend on the specific underlying genetic cause and may involve other organ systems. Conditions grouped under this category include various forms of gonadal dysgenesis, premature ovarian insufficiency, and other rare genetic causes of primary gonadal failure. Treatment is generally supportive and focused on hormone replacement therapy to induce and maintain secondary sexual characteristics and protect bone health. Estrogen and progesterone replacement is used in females, while testosterone replacement is used in males. Fertility treatments, including assisted reproductive technologies, may be considered depending on the specific diagnosis. Management typically requires a multidisciplinary approach involving endocrinologists, reproductive specialists, and genetic counselors.

Common questions about Rare disorder with hypergonadotropic hypogonadism